Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123729014 | 12372901 | 4 | F | 20130801 | 20160630 | 20160516 | 20160712 | EXP | US-009507513-1605USA006314 | MERCK | 55.00 | YR | M | Y | 113.38000 | KG | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123729014 | 12372901 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | UNK, QD | U | L008409 | 21995 | FILM-COATED TABLET | QD | ||||||
| 123729014 | 12372901 | 2 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 3 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 4 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 5 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 6 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | U | 0 | TABLET | |||||||||
| 123729014 | 12372901 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | U | 0 | TABLET | |||||||||
| 123729014 | 12372901 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 10 | C | FIBER | PSYLLIUM HUSK | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 11 | C | BIOTIN | BIOTIN | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | U | 0 | TABLET | |||||||||
| 123729014 | 12372901 | 13 | C | VITAMIN C | ASCORBIC ACID | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 14 | C | ALLOPURINOL. | ALLOPURINOL | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 15 | C | FOLIC ACID. | FOLIC ACID | 1 | U | 0 | |||||||||||
| 123729014 | 12372901 | 16 | C | VITAMIN D3 FRESENIUS | 2 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123729014 | 12372901 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123729014 | 12372901 | DS |
| 123729014 | 12372901 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123729014 | 12372901 | Arthralgia | |
| 123729014 | 12372901 | Gait disturbance | |
| 123729014 | 12372901 | Periarthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |